المؤلفون: Shahswar, Rabia, Beutel, Gernot, Gabdoulline, Razif, Koenecke, Christian, Markel, Dominik, Eder, Matthias, Stadler, Michael, Gohring, Gudrun, Schlegelberger, Brigitte, Trummer, Arne, Krauter, Juergen, Thol, Felicitas, Heuser, Michael

المصدر: http://lobid.org/resources/99370678538206441#!, 100(2):595-599.

مصطلحات موضوعية: Bridged Bicyclo Compounds, Heterocyclic/adverse effects [MeSH], Female [MeSH], Antineoplastic Agents/adverse effects [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Heterocyclic/administration, Adult [MeSH], Cytarabine/therapeutic use [MeSH], Azacitidine/therapeutic use [MeSH], Humans [MeSH], Middle Aged [MeSH], Risk Factors [MeSH], Letter to the Editor, Oncology, Sulfonamides/administration, Decitabine/therapeutic use [MeSH], Hematology, Sulfonamides/adverse effects [MeSH], Male [MeSH], Antineoplastic Agents/therapeutic use [MeSH], Leukemia, Myeloid, Acute/drug therapy [MeSH], Acute/physiopathology [MeSH], Tumor Lysis Syndrome/etiology [MeSH]

Relation: https://repository.publisso.de/resource/frl:6466988; https://doi.org/10.1007/s00277-020-04181-5; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817590/

الاتاحة: https://repository.publisso.de/resource/frl:6466988
https://doi.org/10.1007/s00277-020-04181-5
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817590/